SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-22-117757
Filing Date
2022-04-25
Accepted
2022-04-25 16:53:11
Documents
14
Period of Report
2022-06-10

Document Format Files

Seq Description Document Type Size
1 DEF 14A d343884ddef14a.htm DEF 14A 553139
2 GRAPHIC g343884g00m46.jpg GRAPHIC 19864
3 GRAPHIC g343884g01a01.jpg GRAPHIC 79666
4 GRAPHIC g343884g01x01.jpg GRAPHIC 240619
5 GRAPHIC g343884g02a01.jpg GRAPHIC 31294
6 GRAPHIC g343884g02x01.jpg GRAPHIC 153805
7 GRAPHIC g343884g04x62.jpg GRAPHIC 27601
8 GRAPHIC g343884g04y63.jpg GRAPHIC 19982
9 GRAPHIC g343884g04z65.jpg GRAPHIC 29163
10 GRAPHIC g343884g49j70.jpg GRAPHIC 28904
11 GRAPHIC g343884g63f78.jpg GRAPHIC 24007
12 GRAPHIC g343884g65m25.jpg GRAPHIC 59577
13 GRAPHIC g343884g74d27.jpg GRAPHIC 21043
14 GRAPHIC g343884g99h38.jpg GRAPHIC 55485
  Complete submission text file 0001193125-22-117757.txt   1619816
Mailing Address 1616 EASTLAKE AVE E, SUITE 208 SEATTLE WA 98102
Business Address 1616 EASTLAKE AVE E, SUITE 208 SEATTLE WA 98102 (206) 737-0085
Icosavax, Inc. (Filer) CIK: 0001786255 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40655 | Film No.: 22850398
SIC: 2836 Biological Products, (No Diagnostic Substances)